![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novartis Stops Breast Cancer Study Early Following Positive Results
Novartis Stops Breast Cancer Study Early Following Positive Results
Novartis halted a Phase 3 trial early for a breast cancer candidate after meeting its primary endpoint of clinically meaningful improvement.
The candidate treatment, in combination with letrozole, was found to significantly extend progression-free survival when compared to letrozole alone, the Swiss drug giant says.
Upcoming Events
-
21Oct